Profound Medical Announces Details for 2023 Virtual Analyst & Investor Day
Profound Medical Corp. has released additional information regarding its upcoming Analyst & Investor Day event scheduled for October 13, 2023. The agenda for the virtual event will feature presentations on TULSA-PRO®, a medical technology that offers customizable, incision-free therapies for the treatment of prostate diseases. Key opinion leaders from the United States will share their experiences with TULSA-PRO®, while Profound's management team will provide updates on clinical, technological, and commercial aspects. Testimonials from patients who have undergone the TULSA procedure will also be shared during the event.
The agenda for the event is as follows:
- 1:00-1:05 p.m.: Welcome & Introduction
- 1:05-1:45 p.m.: TULSA-PRO® Surgeon User Presentations
- 1:45-1:50 p.m.: TULSA Patient Testimonials
- 1:50-3:05 p.m.: Profound Management Presentations
- 3:05-3:20 p.m.: Q&A
- 3:20-3:30 p.m.: Closing Remarks
The live interactive event will be hosted on Profound Medical Corp.'s website, and preregistration is required. For those unable to attend the event live, an archive recording will be made available on the website after the conclusion of the live event.
Profound Medical Corp. is a commercial-stage medical device company that specializes in customizable, incision-free therapies for the ablation of diseased tissue. Their flagship technology, TULSA-PRO®, combines real-time MRI, robotically-driven transurethral ultrasound, and closed-loop temperature feedback control to provide precise and radiation-free ablation of the prostate while protecting surrounding structures. The company is also involved in the commercialization of Sonalleve®, a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
Implications of Profound Medical's 2023 Analyst & Investor Day for New Businesses
Profound Medical Corp.'s announcement of its 2023 Analyst & Investor Day offers valuable insights for new businesses, particularly those in the medical technology sector.
Role of Innovative Technologies
The event will focus on TULSA-PRO®, a cutting-edge medical technology that provides customizable, incision-free therapies for prostate diseases. This underscores the importance of innovation in medical technology, a key consideration for new businesses in this sector.
Value of Expert Opinions and Patient Testimonials
The inclusion of presentations by key opinion leaders and testimonials from patients highlights the value of expert validation and user experiences in promoting a product or service. This can serve as a useful strategy for new businesses seeking to build credibility and trust in their offerings.
Importance of Clear Communication
Profound's approach to sharing updates on its clinical, technological, and commercial progress demonstrates the importance of clear and transparent communication with investors and stakeholders. This is a crucial aspect of business operations that new businesses should consider.
In conclusion, Profound Medical's upcoming Analyst & Investor Day not only provides insights into the company's innovative technologies and strategies but also offers valuable lessons for new businesses in terms of product validation, communication, and the role of innovation.